Heart Disease News and Research

Latest Heart Disease News and Research

Perceived racism linked to elevated risk of self-reported sleep disturbance

Perceived racial discrimination is associated with an increased risk of sleep disturbance, which may have a negative impact on mental and physical health, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.

14 Jun 2011

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II diagnostic test, clearing the way for its sale in the United States.

14 Jun 2011

Tiotropium Respimat inhalers can increase risk of death in patients with bronchitis, emphysema

An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research by the University of East Anglia (UEA) and three US universities.

14 Jun 2011

Mother to donate her womb to daughter

A 56-year-old mother hopes to become the first woman to have her womb transplanted into her daughter. Eva Ottoson who lives in Nottinghamshire has agreed to take part in the medical procedure that would see her donate her uterus to her daughter.

13 Jun 2011

Nose spray vaccine for type 1 diabetes could be a reality soon

Melbourne researchers are nearing the development of a vaccine for type 1 diabetes, after showing that a nasal spray can stop the body's immune system from attacking insulin-producing cells.

13 Jun 2011

Milestone completes $13 million round of equity financing

Milestone Pharmaceuticals Inc., a cardiovascular drug development company, announces the completion of a $13 million round of equity financing.

13 Jun 2011

Severe sleep apnea increases risk of gestational diabetes and preterm birth in pregnant women

Sleep apnea is associated with an increased risk of adverse pregnancy outcomes, suggests a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).

13 Jun 2011

New drug more effective than standard treatment to prevent heart-attack deaths

Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.

13 Jun 2011

Servier, Cortex sign new option agreement for AMPAKINE technology

Cortex Pharmaceuticals, Inc. entered into a new agreement with Servier to sell its remaining rights to the jointly discovered high impact AMPAKINE compound, CX1632.

13 Jun 2011

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011, Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.

13 Jun 2011

Left ventricular assist device increases incidence of internal bleeding in heart failure patients

The incidence of internal bleeding was higher in the most commonly implanted heart device than in an earlier model, according to two studies at Henry Ford Hospital in Detroit.

13 Jun 2011

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Kareus Therapeutics SA, the company focused on the development of novel therapeutics to address high unmet medical need, today announced a broad strategic alliance with Quintiles to progress the development of two of Kareus' pre-clinical programs through clinical trials.

13 Jun 2011

Alliance receives $23.2M RWJF grant to extend Healthy Schools Program through 2014

The Alliance for a Healthier Generation, founded by the American Heart Association and the William J. Clinton Foundation, announced today it has received a $23.2 million grant from the Robert Wood Johnson Foundation (RWJF) to expand and extend its Healthy Schools Program through 2014.

13 Jun 2011

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Among Medicare patients with heart attack in 4 California counties, diversion of ambulance traffic by the nearest emergency department for 12 hours or more was associated with an increased risk of death for up to one year, according to a study in the June 15 issue of JAMA.

13 Jun 2011

Unique approach improves discharge disposition and older patient's outcomes

The rehospitalization of senior patients within 30 days of discharge from a skilled nursing facility (SNF) has risen dramatically in recent years, at an estimated annual cost of more than $17 billion.

13 Jun 2011

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Only 35% of anaesthesiologists are carrying out a simple procedure during high-risk surgery that can make a significant impact on how well patients recover from their operations, according to new research presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.

13 Jun 2011

Preliminary results from Edison's EPI-A0001 28-day phase 2A trial against Friedreich's ataxia

Edison Pharmaceuticals, Inc. announced today preliminary results obtained on a 28-day phase 2A clinical trial in Friedreich's ataxia. While the primary endpoint of glucose disposition index did not show statistically significant improvement, EPI-A0001 did significantly improve neurological function as assessed by the Friedreich's Ataxia Rating Scale.

10 Jun 2011

Mortality from all causes higher among hepatitis C-infected patients, study finds

Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases and now available online sought to determine mortality from all causes, including liver- and non-liver related deaths among hepatitis C patients in the general U.S. population. The analysis found mortality from all causes to be higher in these patients.

10 Jun 2011

Larger trial study needed to decide fate of niacin

Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol).

10 Jun 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Perceived racism linked to elevated risk of self-reported sleep disturbance

FDA clears Mitsubishi's PATHFAST cardiac Troponin I diagnostic test

Tiotropium Respimat inhalers can increase risk of death in patients with bronchitis, emphysema

Mother to donate her womb to daughter

Nose spray vaccine for type 1 diabetes could be a reality soon

Milestone completes $13 million round of equity financing

Severe sleep apnea increases risk of gestational diabetes and preterm birth in pregnant women

New drug more effective than standard treatment to prevent heart-attack deaths

Servier, Cortex sign new option agreement for AMPAKINE technology

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Left ventricular assist device increases incidence of internal bleeding in heart failure patients

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Alliance receives $23.2M RWJF grant to extend Healthy Schools Program through 2014

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Unique approach improves discharge disposition and older patient's outcomes

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Preliminary results from Edison's EPI-A0001 28-day phase 2A trial against Friedreich's ataxia

Mortality from all causes higher among hepatitis C-infected patients, study finds

Larger trial study needed to decide fate of niacin

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in